MICHAEL JUSTUS: Open Payments
NPI 1538330220 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 105 payments from 21 companies in 2025. Trend: 2023 $1,395 · 2024 $1,893 · 2025 $1,951
Food & beverage: $1,951
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $424 |
| PFIZER INC. | 22 | $292 |
| UCB, Inc. | 14 | $247 |
| SK Life Science, Inc. | 9 | $186 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Biogen, Inc. | 4 | $94 |
| Neurelis, Inc. | 4 | $89 |
| Amgen Inc. | 3 | $71 |
| Celgene Corporation | 4 | $71 |
| Genentech USA, Inc. | 2 | $49 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, Nayzilam, KESIMPTA, VUMERITY, VALTOCO, UPLIZNA.
Industry payments across AR — which companies pay providers there.
